New drug shows promise for kidney disease patients with inflammation
NCT ID NCT05379829
First seen Oct 31, 2025 · Last updated Jun 05, 2026 · Updated 31 times
Summary
This study tested a drug called ziltivekimab in 24 Chinese adults with chronic kidney disease and signs of inflammation. Participants received either the drug or a placebo (dummy injection) three times over several weeks. The goal was to see how the drug moves through the body and if it is safe, with follow-up lasting about 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE AND SYSTEMIC INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Hospital
Beijing, Beijing Municipality, 100730, China
-
Chinses People's Liberation Army General Hospital-Nephrology
Beijing, Beijing Municipality, 100853, China
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
-
The First Affiliated Hospital Of Soochow University
Suzhou, Jiangsu, 215006, China
-
The First Affiliated Hospital of Soochow University-Endocrinology
Suzhou, Jiangsu, 215006, China
-
Zhongda Hospital Southeast University-Nephrology
Nanjing, Jiangsu, 210009, China
-
Zhongda Hospital Southeast University-Neurology
Nanjing, Jiangsu, 210009, China
Conditions
Explore the condition pages connected to this study.